GLATIRAMER (gla TIR a mer) helps to decrease the number of multiple sclerosis relapses in people with relapsing-remitting forms of the disease. The medicine does not cure multiple sclerosis.
Glatiramer acetate (also known as Copolymer 1, Cop-1, or Copaxone - as
marketed by Teva Pharmaceuticals) is an immunomodulator drug currently used
Glatiramer is used to reduce episodes of symptoms in patients with relapsing-
remitting forms (course of disease where symptoms flare up from time to time) of ...
Easy to read patient leaflet for glatiramer. Includes indications, proper use,
special instructions, precautions, and possible side effects.
Glatiramer acetate, the active ingredient of COPAXONE, consists of the acetate
salts of synthetic polypeptides, containing four naturally occurring amino acids: ...
Find patient medical information for glatiramer subcutaneous on WebMD
including its uses, side effects and safety, interactions, pictures, warnings and
Apr 16, 2014 ... Consumer information about the medication GLATIRAMER - INJECTION (
Copaxone), includes side effects, drug interactions, recommended ...
Jun 19, 2015 ... A generic equivalent of daily Copaxone® (glatiramer acetate, 20 mg), called “
Glatopa”™ (Sandoz, a Novartis company, developed in ...
Sep 18, 2014 ... A new analysis from the UK has suggested that both beta-interferon and
glatiramer acetate delay disability and are cost-effective for the ...
Glatiramer acetate is a synthetic protein that simulates myelin basic protein, a
component of the myelin that insulates nerve fibers in the brain and spinal cord.